Related Experiment Video
Updated: Aug 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Middle ear fluid Streptococcus pneumoniae serotype distribution in Costa Rican children with otitis media
Adriano Arguedas1, Ron Dagan, Silvia Guevara
1Instituto de Atención Pediátrica, San José, Costa Rica. aarguedas@iped.net
Insights
The heptavalent pneumococcal conjugate vaccine covers 74% of Streptococcus pneumoniae causing otitis media in Costa Rican children. Serotype distribution in pediatric middle ear fluid is similar to developed countries.
Area of Science:
- Pediatric infectious diseases
- Microbiology
- Vaccinology
Background:
- Streptococcus pneumoniae conjugate vaccine introduced in Costa Rica in 2004.
- Previous data (1999-2001) showed serotype 19F prevalence at 75% in pediatric middle ear fluid (MEF).
- Recent shifts in prevalent serotypes necessitate updated epidemiological data.
Purpose of the Study:
- Identify common S. pneumoniae serotypes in MEF of Costa Rican children with otitis media (OM).
- Analyze serotype distribution by demographics, disease characteristics, and antimicrobial susceptibility.
- Assess the coverage of the heptavalent S. pneumoniae conjugate vaccine for OM in this population.
Main Methods:
- Collected 69 S. pneumoniae isolates from MEF of children (3-49 months) with OM in 2002-2003.
- Performed serotyping using the quellung reaction with Statens Serum Institute antisera.
Main Results:
- Most common serotypes: 19F (26.1%), 6B (14.5%), 9V (8.7%), 16F (8.7%), 14 (5.8%), 23F (5.8%), 3 (5.8%), and 6A (5.8%).
- Serotype distribution showed no significant differences based on age or disease distribution.
- A trend indicated higher non-susceptibility to penicillin and trimethoprim-sulfamethoxazole among vaccine-type strains.
Conclusions:
- S. pneumoniae serotype distribution causing pediatric OM in Costa Rica resembles that of developed nations.
- The current heptavalent pneumococcal conjugate vaccine is estimated to cover 74% of OM cases in Costa Rican children.
Background:
Streptococcus pneumoniae conjugate vaccine became available in Costa Rica in 2004. Previous S. pneumoniae middle ear fluid (MEF) data obtained during the period 1999-2001 from Costa Rican children indicated that serotype 19F was the most common type (75%), but more recently other serotypes have become more prevalent.
Objectives:
To establish the most common S. pneumoniae serotypes present in the MEF of Costa Rican children with otitis media (OM) and to analyze serotype distribution by demographic factors, disease distribution and antimicrobial susceptibility patterns and assess the potential protection provided by the new conjugated heptavalent S. pneumoniae vaccine in Costa Rican children with OM.
Methods:
During 2002 and 2003, 69 S. pneumoniae isolates were obtained from the MEF of Costa Rican children, ages 3-49 months, with OM. Serotyping was performed by the quellung reaction with antisera from Statens Serum Institute, Copenhagen, Denmark.
Results:
The most common S. pneumoniae serotypes isolated were 19F (26.1%), 6B (14.5%), 9V (8.7%), 16F (8.7%), 14 (5.8%), 23F (5.8%), 3 (5.8%) and 6A (5.8%). Serotype distribution was similar among children younger than 24 months of age or 24 months of age or older and by disease distribution. There was a tendency towards more penicillin- and trimethoprim-sulfamethoxazole-nonsusceptible isolates among vaccine-type strains than among non-vaccine type strains.
Conclusions:
The serotype distribution of S. pneumoniae causing pediatric OM in Costa Rica is similar to those reported from developed countries. The current heptavalent pneumococcal conjugate vaccine covers 74% of OM episodes in Costa Rican children.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease
Atypical Pneumonia
Microbiota of the Respiratory Tract
Streptococcal Pharyngitis
